MerTK regulates thymic selection of autoreactive T cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 12, 2009, Pages 4810-4815

  Wallet, Mark A ^a   Flores, Rafael R ^a   Wang, Yaming ^a   Yi, Zuoan ^a   Kroger, Charles J ^a   Mathews, Clayton E ^a   Earp, H Shelton ^a,b   Matsushima, Glenn ^a,b,c   Wang, Bo ^a   Tisch, Roland ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Dendritic cells; Receptor tyrosine kinase; Type 1 diabetes

Indexed keywords

MER TYROSINE KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; MERTK PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ISOLATION; CELL SELECTION; DENDRITIC CELL; IMMUNOREACTIVITY; IMMUNOREGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYMOCYTE; ANIMAL; BONE MARROW CELL; CYTOLOGY; ENZYMOLOGY; FEMALE; GENETIC SELECTION; IMMUNITY; IMMUNOLOGY; MALE; METABOLISM; PANCREAS ISLET BETA CELL; PATHOLOGY; THYMUS;

MUS;

ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNITY; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED NOD; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SELECTION (GENETICS); T-LYMPHOCYTES; THYMUS GLAND;

EID: 63849156298     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900683106     Document Type: Article

References (32)

1. Bouneaud C, Kourilsky P, Bousso P (2000) Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion. Immunity 13:829-840.
2. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775-787.
3. Pechhold K, Koczwara K (2008) Immunomodulation of autoimmune diabetes by dendritic cells. Curr Diab Rep 8:107-113.
4. Brocker T, Riedinger M, Karjalainen K (1997) Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 185:541-550.
5. Delaney JR, Sykulev Y, Eisen HN, Tonegawa S (1998) Differences in the level of expression of classI major histocompatibility complex proteinson thymic epithelial and dendritic cells influence the decision of immature thymocytes between positive and negative selection. Proc Natl Acad Sci USA 95:5235-5240.
6. Ashton-Rickardt P, et al. (1994) Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651-663.
7. Anderson G, Moore N, Owen J, Jenkinson E (1996) Cellular interactions in thymocyte development. Annu RevImmunol 14:73-99.
8. Tisch R, McDevittH (1996) Insulin-dependent diabetes mellitus. Cell 85:291-297.
9. g7-dependent reaction. Proc Natl Acad Sci USA 95:1721-1724.
10. Jurewicz A, Biddison WE, Antel JP (1998) MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol 160:3056-3059.
11. Panayi GS, Lanchbury JS, Kingsley GH (1992) The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735.
12. Maier LM, Wicker LS (2005) Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 17:601-608.
13. Anderson MS,Bluestone JA(2005)The NOD mouse: Amodel of immune dysregulation. Ann Rev Immunol 23:447-485.
14. Zucchelli S, et al. (2005) Defective central tolerance induction in NOD mice: Genomics and genetics. Immunity22:385-396.
15. Liston A, et al. (2004) Generalized resistance to thymic deletion in the NOD mouse: a polygenic traitcharacterized by defective induction of Bim. Immunity 21:817-830.
16. Schuler G, Steinman RM (1985)Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161:526-546.
17. Wallet MA, Sen P, Tisch R (2005) Immunoregulation of dendritic cells. Clin Med Res 3:166-175.
18. Wallet MA, et al. (2008) MerTK is required for apoptotic cell-induced T cell tolerance. J Exp Med 205:219-232.
19. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G (2007) TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131:1124-1136.
20. Sen P, et al. (2007) Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109:653-660.
21. Todt JC, Hu B, Curtis JL (2004) The receptor tyrosine kinase MerTK activates phospholipase Cgamma2 during recognition of apoptotic thymocytes by murine macrophages. J Leukoc Biol 75:705-713.
22. Lemke G, Rothlin CV (2008) Immunobiology of the TAM receptors. Nat Rev Immunol 8:327-336.
23. Linger RM, Keating AK, Earp HS, Graham DK (2008) TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100:35-83.
24. Lu Q, Lemke G (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293:306-311.
25. Behrens EM, et al. (2003) The mer receptor tyrosine kinase: Expression and function suggest a role in innate immunity. Eur J Immunol 33:2160-2167.
26. Shao WH, Eisenberg RA, Cohen PL (2008) The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J Immunol 180:7728-7735.
27. Cohen PL, et al. (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196:135-140.
28. ScottRS,et al. (2001)Phagocytosisand clearance of apoptotic cells is mediated by MER. Nature 411:207-211.
29. Feng W, Yasumura D, Matthes MT, LaVail MM, Vollrath D (2002) Mertktriggers uptake of photoreceptor outer segments during phagocytosis by cultured retinal pigment epithelial cells. JBiol Chem 277:17016-17022.
30. Serreze DV, et al. (1998) Subcongenic analysis of the Idd13 locus in NOD/Lt mice: Evidence for several susceptibility genes including apossible diabetogenic role for beta 2-microglobulin. J Immunol 160:1472-1478.
31. Pop SM, et al. (2007) The type and frequency of immunoregulatory CD4+ T cells governs the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes56:1395-1402.
32. Wong CP, Li L, Frelinger JA, Tisch R (2006) Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice. J Immunol 176:1637-1644.